Given the current economic and political climate, widespread patient need, and burgeoning new product entries, there is increasing focus on the high cost of medical treatment. In response, the pharmaceutical, biotech, drug delivery and medical device industries must proactively highlight the comparative effectiveness and unique competitive advantages of their products. This is a difficult task because head-to-head comparative trials rarely exist. In the absence of these trials, industry must rely upon alternative ways of competitively highlighting product value. Health economics and outcomes research (HEOR) is a scientific discipline that offers powerful tools for identifying, testing and highlighting comparative value.

Our HEOR Core Scientific Offerings are designed to:

• Address gaps in the current knowledge base
• Highlight the clinical and economic burden of a disease/condition
• Evaluate the competitive landscape and pipeline products
• Assess the efficacy and safety of competitive products
• Examine unmet needs within a disease/condition
• Provide evidence of the efficacy and safety of your product
• Develop value propositions and arguments for your product
• Test value propositions and arguments with expert clinicians, academic researchers and payers

BioMedEcon’s Core Scientific Offerings:

• Comparative Effectiveness Research
• Competitive Product Analyses
• Data Synthesis
• Pricing, Coverage and Reimbursement Research
• Pharmacoeconomic Modeling
• Clinical and HEOR Communications